# Intrauterine inflammation and postnatal intravenous dopamine alter the neurovascular unit in preterm newborn lambs

**Authors:** Nhi T. Tran, Nadia Hale, Anawar Aung Win Maung, Manon Wiersma, David W. Walker, Graeme Polglase, Margie Castillo-Melendez, Flora Y. Wong

PMC · DOI: 10.1186/s12974-024-03137-0 · 2024-05-28

## TL;DR

Intrauterine inflammation and dopamine treatment in preterm lambs disrupt brain structures important for blood flow and brain development.

## Contribution

This study reveals structural changes in the neurovascular unit caused by inflammation and dopamine in preterm lambs.

## Key findings

- LPS exposure increases vascular leakage and alters tight junction proteins in preterm lamb brains.
- Dopamine administration reduces vessel density and affects pericyte coverage and oxidative stress markers.
- Dopamine does not worsen LPS-induced changes in the neurovascular unit.

## Abstract

Intrauterine inflammation is considered a major cause of brain injury in preterm infants, leading to long-term neurodevelopmental deficits. A potential contributor to this brain injury is dysregulation of neurovascular coupling. We have shown that intrauterine inflammation induced by intra-amniotic lipopolysaccharide (LPS) in preterm lambs, and postnatal dopamine administration, disrupts neurovascular coupling and the functional cerebral haemodynamic responses, potentially leading to impaired brain development. In this study, we aimed to characterise the structural changes of the neurovascular unit following intrauterine LPS exposure and postnatal dopamine administration in the brain of preterm lambs using cellular and molecular analyses.

At 119–120 days of gestation (term = 147 days), LPS was administered into the amniotic sac in pregnant ewes. At 126-7 days of gestation, the LPS-exposed lambs were delivered, ventilated and given either a continuous intravenous infusion of dopamine at 10 µg/kg/min or isovolumetric vehicle solution for 90 min (LPS, n = 6; LPSDA, n = 6). Control preterm lambs not exposed to LPS were also administered vehicle or dopamine (CTL, n = 9; CTLDA, n = 7). Post-mortem brain tissue was collected 3–4 h after birth for immunohistochemistry and RT-qPCR analysis of components of the neurovascular unit.

LPS exposure increased vascular leakage in the presence of increased vascular density and remodelling with increased astrocyte “end feet” vessel coverage, together with downregulated mRNA levels of the tight junction proteins Claudin-1 and Occludin. Dopamine administration decreased vessel density and size, decreased endothelial glucose transporter, reduced neuronal dendritic coverage, increased cell proliferation within vessel walls, and increased pericyte vascular coverage particularly within the cortical and deep grey matter. Dopamine also downregulated VEGFA and Occludin tight junction mRNA, and upregulated dopamine receptor DRD1 and oxidative protein (NOX1, SOD3) mRNA levels. Dopamine administration following LPS exposure did not exacerbate any effects induced by LPS.

LPS exposure and dopamine administration independently alters the neurovascular unit in the preterm brain. Alterations to the neurovascular unit may predispose the developing brain to further injury.

The online version contains supplementary material available at 10.1186/s12974-024-03137-0.

## Linked entities

- **Genes:** CLDN7 (claudin 7) [NCBI Gene 1366], si:ch73-61d6.3 (uncharacterized si:ch73-61d6.3) [NCBI Gene 103182021], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422], DRD1 (dopamine receptor D1) [NCBI Gene 1812], NOX1 (NADPH oxidase 1) [NCBI Gene 27035], SOD3 (superoxide dismutase 3) [NCBI Gene 6649]
- **Chemicals:** dopamine (PubChem CID 681)
- **Species:** Ovis aries (taxon 9940)

## Full-text entities

- **Genes:** Occludin [NCBI Gene 443201], DRD1 [NCBI Gene 100568292], Claudin-1 [NCBI Gene 780473], VEGFA [NCBI Gene 443103], NOX1 [NCBI Gene 100034667], SOD3 [NCBI Gene 101104150]
- **Diseases:** impaired brain development (MESH:D002658), inflammation (MESH:D007249), Intrauterine (MESH:D005317), infants (MESH:D063766), neurodevelopmental deficits (MESH:D009461), brain injury (MESH:D001930)
- **Chemicals:** LPS (MESH:D008070), Dopamine (MESH:D004298), LPSDA (-)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11134744/full.md

---
Source: https://tomesphere.com/paper/PMC11134744